Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Forecasted to Post Q1 2025 Earnings of ($0.05) Per Share

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Research analysts at Alliance Global Partners issued their Q1 2025 earnings estimates for shares of Curaleaf in a research report issued to clients and investors on Thursday, August 8th. Alliance Global Partners analyst A. Grey expects that the company will earn ($0.05) per share for the quarter. The consensus estimate for Curaleaf’s current full-year earnings is ($0.21) per share.

Separately, Needham & Company LLC reissued a “buy” rating and issued a $6.25 price target on shares of Curaleaf in a research report on Thursday.

Curaleaf Stock Performance

Shares of OTCMKTS CURLF opened at $3.38 on Friday. The business’s 50-day simple moving average is $4.05 and its 200-day simple moving average is $4.74. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.36 and a current ratio of 0.72. Curaleaf has a 52 week low of $2.51 and a 52 week high of $6.40. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of -8.66 and a beta of 0.88.

Curaleaf (OTCMKTS:CURLF) last posted its earnings results on Thursday, May 9th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.01). The business had revenue of $338.93 million for the quarter, compared to analyst estimates of $341.25 million. Curaleaf had a negative return on equity of 14.43% and a negative net margin of 20.29%.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.